Response to US review rules on patent subject matter of traditional Chinese medicine compositions / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 627-630, 2018.
Article
in Zh
| WPRIM
| ID: wpr-771691
Responsible library:
WPRO
ABSTRACT
The United States Patent and Trademark Office(USPTO) issued Interim Guidance on Patent Subject Matter Eligibility on December 16, 2014, bringing certain effects to the review rules on patent application of Chinese medicine compositions. Based on the Interim Guidance, cases analysis was used in this paper to analyze the patent subject matter issues of traditional Chinese medicine compositions in the United States. The researches have shown that the application documents should be properly written in the United States when the patent for Chinese medicine compositions is applied, which can improve the probability of authorization.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Patents as Topic
/
Reference Standards
/
Research
/
United States
/
Drugs, Chinese Herbal
/
Chemistry
/
Medicine, Chinese Traditional
Type of study:
Diagnostic_studies
Country/Region as subject:
America do norte
Language:
Zh
Journal:
China Journal of Chinese Materia Medica
Year:
2018
Type:
Article